David Schaffer
Director, uniQure N.V.
Companies
- 4D Molecular Therapeutics, Inc.Board member Dec 10, 2020 to Oct 22, 20211
- uniQure N.V.Board member Jan 3, 2017 to Mar 2, 20202
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
4D Molecular Therapeutics, Inc. FDMT901,215 shares3$10.9M at $12.14Oct 22, 2021
As of each latest filing. The line shows shares held over time.
Recent filings
- Oct 22, 2021Sold 1,900 shares at $31.00 of 4D Molecular Therapeutics, Inc.3
- Oct 21, 2021Sold 22,820 shares at $31.56 of 4D Molecular Therapeutics, Inc.3
- Oct 20, 2021Sold 11,565 shares at $31.02 of 4D Molecular Therapeutics, Inc.3
- Sep 30, 2021Sold 4,549 shares at $27.28 of 4D Molecular Therapeutics, Inc.4
- Sep 30, 2021Sold 7,836 shares at $26.69 of 4D Molecular Therapeutics, Inc.4
- Sep 29, 2021Sold 700 shares at $30.06 of 4D Molecular Therapeutics, Inc.4
- Sep 29, 2021Sold 8,365 shares at $29.06 of 4D Molecular Therapeutics, Inc.4
- Sep 29, 2021Sold 7,806 shares at $27.99 of 4D Molecular Therapeutics, Inc.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARuniQure N.V., Board member
- 3
- 4SEC EDGARForm 4 filed Oct 1, 2021